Amide Lipid Sunscreen Compounds for UVB Protection With Reduced Cytotoxicity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Commercial sunscreens contain ingredients that pose health and environmental risks, necessitating the development of safer, more effective UV-protective compounds.

Innovation Solution

Development of amide lipid conjugates of benzyl isothiocyanates, such as (Z)—N-(3-methoxybenzyl)eicos-5-enamide, derived from meadowfoam fatty acids, which absorb UVB light and reduce UV-induced DNA damage with reduced cytotoxicity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If commercial sunscreen ingredients (oxybenzone, titanium dioxide, zinc oxide) are used, then UV protection is provided, but health and environmental risks increase

Engineering Contradiction:
ImproveUV protection effectivenessVSAvoidhealth and environmental risks
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the chemical structure of UV-filtering compounds by creating amide lipid conjugates of benzyl isothiocyanates. This structural parameter change maintains UV absorption capability while reducing cytotoxicity and environmental harm, directly resolving the contradiction between effectiveness and safety

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention combines benzyl isothiocyanate moieties with lipid structures to create composite molecules that function as both UV filters and skin-compatible compounds. The composite structure integrates the UV-absorbing aromatic ring with biocompatible lipid chains, achieving both protection and reduced toxicity

Inventive Principle:
Principle #40Composite materials

2Reliability

If UV-absorbing organic compounds with aromatic rings are used, then UVB protection is achieved, but cytotoxicity increases

Engineering Contradiction:
ImproveUVB absorption capabilityVSAvoidcytotoxic effects on skin cells
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent introduces lipid chains at specific positions on the aromatic ring structure, creating local regions of biocompatibility while maintaining the UV-absorbing aromatic core. This local modification reduces cytotoxicity without sacrificing UVB absorption capability

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention transforms the potentially harmful aromatic ring structure into a beneficial UV-filtering component by attaching lipid chains that reduce cytotoxicity. The aromatic ring's UV-absorbing property is converted into a protective function while the lipid portions mitigate the harmful effects

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The amide lipid conjugates provide photoprotection by absorbing UVB light while minimizing cytotoxic effects on human skin cells, offering a safer alternative to existing sunscreen additives.

Implementation Method 1

UV absorption is due to the presence of an aromatic ring conjugated to a carbonyl group which is a structure capable of absorbing UV, entering an excited state, and then emitting that energy as heat

Methodology Applied
Scientific EffectUV absorption: Absorption (EM radiation)

Data Source

PatentUS20250228757A1Sunscreen compounds and formulations
Publication Date: 2025.07.17 THE STATE OF OREGON ACTING BY & THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION ON BEHALF OF OREGON STATE UNIV
  • US20250228757A1 patent drawing
  • US20250228757A1 patent drawing
  • US20250228757A1 patent drawing

AI summary

Amide lipid conjugates of benzyl isothiocyanates are disclosed. The benzyl isothiocyanate is conjugated to a fatty acid, such as a C12-C26 fatty acid. The disclosed amide lipid conjugates have a structure according to Formula I, where one of R1A and R1B is alkoxy or hydroxy, and the other of R1A and R1B is —H; and R2 is C12-C26 aliphatic. Sunscreen formulations include a compound according to Formula I and one or more excipients. The sunscreen formulation may further include one or more additional sunscreen active agents.